TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/16/24 16:35 | 12/13/24 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Hutson Nancy J | NC | D | S | -53 | 7.54 | 0 | -7 | -7 | 87 | D | |||||||||||||||
5/22/24 07:24 | 5/20/24 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Hutson Nancy J | CT | D | P | 32 | 6.38 | 0 | 5 | 6 | 87 | D | |||||||||||||||
10/4/23 17:06 | 10/3/23 | CLSD | Clearside Biomedical, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hutson Nancy J | GA | D | P | 9 | 0.8600 | 0 | 10 | 12 | 93 | D | |||||||||||||||
6/15/23 16:33 | 6/14/23 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Hutson Nancy J | CT | D | S.d | -103 | 8.04 | 0 | -13 | -14 | 82 | D | |||||||||||||||
5/19/23 16:15 | 5/19/23 | PHAS | Phasebio Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Hutson Nancy J | DE | D | M.d | 0 | 0.00 | 0 | 4 | 10 | 42 | D | |||||||||||||||
11/21/22 08:12 | 11/17/22 | CLSD | Clearside Biomedical, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hutson Nancy J | GA | D | P | 40 | 1.33 | 0 | 30 | 57 | 83 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |